Table 3 Cardiovascular control markers evaluated in CAS patients in PRE, FU6 and FU12 at REST and during STAND.
CAS | REST | STAND | ||||
---|---|---|---|---|---|---|
PRE | FU6 | FU12 | PRE | FU6 | FU12 | |
µHP [ms] | 851.20 ± 149.97 | 886.93 ± 111.87§ | 917.64 ± 130.77§ | 768.11 ± 132.42* | 821.81 ± 122.32*,§ | 859.64 ± 108.29*,§ |
σ2HP [ms2] | 595.97 ± 822.06 | 521.72 ± 610.72 | 559.74 ± 694.53 | 257.66 ± 240.27* | 364.91 ± 414.46 | 549.17 ± 498.72§ |
HFHP [ms2] | 143.13 ± 267.38 | 125.74 ± 159.58 | 119.27 ± 140.05 | 43.85 ± 42.64* | 97.74 ± 156.67§ | 123.79 ± 172.56 |
LFHP/HFHP | 1.34 ± 1.94 | 1.11 ± 1.93 | 0.82 ± 0.91 | 1.34 ± 1.64 | 1.47 ± 3.64 | 0.80 ± 1.06 |
µSAP [mmHg] | 148.97 ± 27.43 | 147.47 ± 21.36 | 147.48 ± 24.41 | 143.24 ± 24.79 | 143.45 ± 30.9 | 146.85 ± 24.94 |
σ2SAP [mmHg2] | 24.61 ± 18.41 | 30.53 ± 48.49 | 21.82 ± 12.9 | 43.76 ± 29.06 | 30.23 ± 26.55 | 36.09 ± 32.72 |
LFSAP [mmHg2] | 3.92 ± 4.24 | 2.39 ± 3.40 | 1.89 ± 1.52 | 6.27 ± 7.19 | 4.52 ± 6.76 | 2.92 ± 2.43 |
αLF [ms/mmHg] | 8.27 ± 20.01 | 7.04 ± 7.64 | 6.47 ± 6.7 | 2.56 ± 1.91 | 3.64 ± 2.7* | 5.06 ± 4.25 |
αHF [ms/mmHg] | 5.64 ± 5.80 | 6.35 ± 6.06 | 5.9 ± 5.22 | 2.71 ± 1.71 | 6.19 ± 6.87§ | 4.32 ± 2.88 |
K2LF | 0.31 ± 0.20 | 0.37 ± 0.20 | 0.34 ± 0.2 | 0.31 ± 0.18 | 0.43 ± 0.23 | 0.28 ± 0.18# |
PhLF [rad] | -0.62 ± 1.66 | -0.97 ± 1.83 | -0.60 ± 1.74 | -0.83 ± 1.70 | -0.98 ± 1.46 | -1.35 ± 1.41 |
BRSLF [ms/mmHg] | 3.50 ± 3.74 | 4.80 ± 5.03 | 4.77 ± 6.38 | 1.64 ± 1.28 | 2.96 ± 2.61 | 3.00 ± 3.37 |
K2HF | 0.65 ± 0.25 | 0.69 ± 0.24 | 0.67 ± 0.24 | 0.63 ± 0.23 | 0.66 ± 0.23 | 0.57 ± 0.26 |
PhHF [rad] | -0.13 ± 0.84 | -0.27 ± 1.14 | 0.13 ± 1.22 | -0.11 ± 1.40 | 0.06 ± 1.23 | 0.35 ± 1.3 |
BRSHF [ms/mmHg] | 5.36 ± 5.64 | 9.15 ± 15.05 | 6.15 ± 7.50 | 2.42 ± 1.96 | 5.56 ± 5.00 | 5.40 ± 5.15 |